ripekg:integrity-assessment-hypothesis/RIPEAAAD6F9051C284833-human-1-1 |
rdf:type |
rdfs:Resource |
ripekg:integrity-assessment-hypothesis/RIPEAAAD6F9051C284833-human-1-1 |
rdf:type |
owl:Thing |
ripekg:integrity-assessment-hypothesis/RIPEAAAD6F9051C284833-human-1-1 |
rdf:type |
ripe:IntegrityAssessmentHypothesisIntegrity assessment hypothesis |
ripekg:integrity-assessment-hypothesis/RIPEAAAD6F9051C284833-human-1-1 |
rdf:type |
tido:Hypothesis |
ripekg:integrity-assessment-hypothesis/RIPEAAAD6F9051C284833-human-1-1 |
prov:wasAttributedTo |
ripekg:human-reviewer/RV019 |
ripekg:integrity-assessment-hypothesis/RIPEAAAD6F9051C284833-human-1-1 |
prov:wasGeneratedBy |
ripekg:evaluation/RIPEAAAD6F9051C284833 |
ripekg:integrity-assessment-hypothesis/RIPEAAAD6F9051C284833-human-1-1 |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEAAAD6F9051C284833 |
ripekg:integrity-assessment-hypothesis/RIPEAAAD6F9051C284833-human-1-1 |
ripe:resultOutcome |
no |
ripekg:integrity-assessment-hypothesis/RIPEAAAD6F9051C284833-human-1-1 |
tido:answers |
ripekg:integrity-assessment-question/retraction-status/1.0.01.1. Does the study have an associated retraction? |
ripekg:integrity-assessment-hypothesis/RIPEAAAD6F9051C284833-human-1-1 |
tido:answers |
ripekg:integrity-assessment-question/retraction-status/1.0.0retraction status |
ripekg:publication-details/RIPEAAAD6F9051C284833Effect of sodium-glucose cotransporter-2 inhibitor on metabolic syndrome in people with prediabetes and obesity: A systematic review and meta-analysis |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEAAAD6F9051C284833-human-1-1 |